Profile
International Journal of Pediatrics & Neonatal Care Volume 5 (2019), Article ID 5:IJPNC-147, 7 pages
https://doi.org/10.15344/2455-2364/2019/147
Review Article
Overview of Malignant Solid Tumors in Neonates

Karen S. Fernández1,2* and Reuben Antony3

1Valley Children’s Health Care, Cancer and Blood Disorders Center, 9300 Valley Children’s Place, Madera, CA 93636, USA
2University of California San Francisco (UCSF)- Fresno, Pediatrics Hematolgy Oncology, 9300 Valley Children’s Place, Madera, CA 93736, USA
3UC Davis Comprehensive Cancer Center, Pediatric Hematology and Oncology, UC Davis Children’s Hospital, 2nd Floor, TICON 2 Building, 2516 Stockton Blvd, Sacramento, CA 95817, USA
Dr. Karen S. Fernández, Valley Children’s Health Care, Cancer and Blood Disorders Center, 9300 Valley Children’s Place, Madera, CA 93636, USA; E-mail: kfernandez@valleychildrens.org
02 October 2018; 27 February 2019; 01 March 2019
Fernández KS, Antony R (2019) Overview of Malignant Solid Tumors in Neonates. Int J Pediatr Neonat Care 5: 147. doi: https://doi.org/10.15344/2455-2364/2019/147

References

  1. Moore SW, Satge D, Sasco AJ, Zimmermann A, Plaschkes J (2003) The epidemiology of neonatal tumours. Report of an international working group. Pediatr Surg Int 19: 509-519. [CrossRef] [Google Scholar] [PubMed]
  2. Bader JL, Miller RW (1979) US cancer incidence and mortality in the first year of life. Am J dis Child 133: 157-159. [CrossRef] [Google Scholar] [PubMed]
  3. Lakhoo K, Sowerbutts H (2010) Neonatal tumours. Pediatr Surg Int 26: 1159-1168. [CrossRef] [Google Scholar] [PubMed]
  4. Campbell AN, Chan HSL, O’Brien A, Smith CR, Becker LE, et al. (1989) Malignancy in the neonate. Med Pediatr Onc 17: 101.
  5. Nuchtern JG (2006) Perinatal neuroblastoma. Semin Pediatr Surg 15: 10-16. [CrossRef] [Google Scholar] [PubMed]
  6. Cozzi DA, Mele E, Ceccanti S, Natale F, Clerico A, et al. (2013) Long-term follow-up of the "wait and see" approach to localized perinatal adrenal neuroblastoma. World J Surg 37: 459-465. [CrossRef] [Google Scholar] [PubMed]
  7. Gopal M, Chahal G, Al-Rifai Z, Eradi B, Ninan G, et al. (2008) Infantile myofibromatosis. Pediatr Surg Int 24: 287-291. [CrossRef] [PubMed]
  8. Buonuomo PS, Ruggiero A, Zampino G, Maurizi P, Attina G, et al. (2006) A newborn with multiple fractures as first presenation of infantile myofibromatosis. J Perinatol 26: 653-655. [CrossRef] [Google Scholar] [PubMed]
  9. Arts FA, Sciot R, Brichard B, Renard M, de Rocca Serra A, et al. (2017) PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis. Hum Mol Genet 26: 1801-1810. [CrossRef] [Google Scholar] [PubMed]
  10. Lobe TE, Wiener ES, Hays DM, Lawrence WH, Andrassy RJ, et al. (1994) Neonatal rhabdomyosarcoma: the IRS experience. J Pediatr Surg 29: 1167-1170. [CrossRef] [Google Scholar] [PubMed]
  11. Russell H, Hicks MJ, Bertuch AA, Chintagumpala M (2009) Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy. Pediatr Blood Cancer 53: 23-27. [CrossRef] [Google Scholar] [PubMed]
  12. Rickert CH (1999) Neuropathology and prognosis of foetal brain tumors. Acta Neuropathol 98: 567-576. [CrossRef] [Google Scholar] [PubMed]
  13. Isaacs H Jr (2016) Perinatal (fetal and neonatal) astrocytoma: a review. Childs Nerv Syst 32: 2085-2209. [CrossRef] [Google Scholar] [PubMed]
  14. Bodeliwala S, Kumar V, Singh D (2017) Neonatal Brain Tumors: A Review. J Neonatal Surg 6: 30. [CrossRef] [PubMed]
  15. Volpe JJ, Robinson S (1995) Chapter 37-Brain tumors and vein malformations. In: Volpe JJ, editor. Neurology of the newborn, (3rd ed) Philadelphia: WB Saunders, pp. 795-807.
  16. Iwama J1, Ogiwara H, Kiyotani C, Terashima K, Matsuoka K, et al. (2015) Neoadjuvant chemotherapy for brain tumors in infants and young children. J Neurosurg Pediatr 15: 488-492. [CrossRef] [Google Scholar] [PubMed]
  17. Van Poppel M, Klimo P Jr, Dewire M, Sanford RA, Boop F, et al. (2011) Resection of infantile brain tumors after neoadjuvant chemotherapy: The St. Jude experience. J Neurosurg Pediatr 8: 251-256. [CrossRef] [Google Scholar] [PubMed]
  18. Sugimoto M, Kurishima C, Masutani S, Tamura M, Senzaki H et al. (2015) Congenital Brain Tumor in the first 2 months of life. Pediatr Neonatol 56: 369-375. [CrossRef] [Google Scholar] [PubMed]
  19. Isaacs H Jr (2008) Fetal and neonatal renal tumors. J Pediatr Surg 43: 1587-1595. [CrossRef] [Google Scholar] [PubMed]
  20. Lakhoo K, Sowerbutts H (2013) Neonatal tumours. Pediatr Surg Int 26:1159-1168. [CrossRef] [Google Scholar] [PubMed]
  21. Lapunzina P (2005) Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet C Semin Med Genet 137C: 53-71. [CrossRef] [Google Scholar] [PubMed]
  22. Gracia Bouthelier R, Lapunzina P (2005) Follow-up and risk of tumors in overgrowth syndromes. J Pediatr Endocrinol Metab 1: 1227-1235. [CrossRef] [Google Scholar] [PubMed]
  23. Isaacs H Jr (2007) Fetal and neonatal hepatic tumors. J Pediatr Surg 42: 1797-1803. [CrossRef] [Google Scholar] [PubMed]
  24. Trobaugh-Lotrario AD, Chaiyachati BH, Meyers RL, Häberle B, Tomlinson GE, et al. (2013) Outcomes for patients with congenital hepatoblastoma. Pediatr Blood Cancer 1817-1825. [CrossRef] [Google Scholar] [PubMed]
  25. Santos XM, Papanna R, Johnson A, Cass DL, Olutoye OO, et al. (2010) The use of combined ultrasound and magnetic resonance imaging in the detection of fetal anomalies. Prenat Diagn 30: 402-407. [CrossRef] [Google Scholar] [PubMed]
  26. Lee TC, Olutoye OO (2012) Evaluation of the prenatally diagnosed mass. Semin Fetal Neonatal Med 17: 185-191. [CrossRef] [Google Scholar] [PubMed]
  27. Chung R, Kasprian G, Brugger PC, Prayer D (2009) The current state and future of fetal imaging. Clin Perinatol 36: 685-699. [CrossRef] [Google Scholar] [PubMed]
  28. Pugash D, Brugger PC, Bettelheim D, Prayer D (2008) Prenatal ultrasound and fetal MRI: The comparative value of each modality in prenatal diagnosis. Euro J Radiol 68: 214-226. [CrossRef] [Google Scholar] [PubMed]
  29. Breysem L, Bosmans H, Dymarkowski S, Schoubroeck DV, Witters I,, et al. (2003) The value of fast MR imaging as an adjunct to ultrasound in prenatal diagnosis. Euro Radiol 13: 1538-1548. [CrossRef] [Google Scholar] [PubMed]
  30. Expert Panel on MR Safety, Kanal E, Barkovich AJ, Bell C, Borgstede JP, et al. (2013) ACR guidance document on MR safe practices: 2013. Expert Panel on MR Safety. J Magn Reson Imaging 37: 501-530. [CrossRef] [Google Scholar] [PubMed]
  31. The American College of Obstetricians and Gynecologists (2016) Committee Opinion No. 656: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstetrics & Gynecology 127: e75-e80. [CrossRef] [Google Scholar] [PubMed]
  32. Albanese CT (2005) The EXIT strategy. Neo Reviews 6: e431-e435.
  33. Bouchard S, Johnson MP, Flake AW, Howell LJ, Myers LB, et al. (2002) The EXIT procedure: experience and outcome in 31 cases. J Pediatr Surg 37: 418-426. [CrossRef] [Google Scholar] [PubMed]
  34. Borsellino A, Zaccara A, Nahom A, Trucchi A, Aite L, et al. (2006) False-positive rate in prenatal diagnosis of surgical anomalies. J Pediatr Surg 41: 826-829. [CrossRef] [Google Scholar] [PubMed]
  35. Isaacs H Jr (1987) Congenital and neonatal malignant tumors. A 28-year experience at Children's Hospital of Los Angeles. Am J Pediatr Hematol Oncol 9:121-129. [Google Scholar] [PubMed]
  36. Kuki I, Kawawaki H, Okazaki S, Ehara E, Yoshida Y, et al. (2018) Efficacy and safety of everolimus in patient younger than 12 months with congenital subependymal giant cell astrocytoma. Brain & Development 40: 415-420. [CrossRef] [Google Scholar] [PubMed]